| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Mendelson Daniel Newman is a Director at CHAMPIONS ONCOLOGY, INC.. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 5,000 | $4.75 | $23,750.00 | +2.9% | +14.5% | +51.5% | |
| Oct 11, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 5,000 | $6.40 | $32,000.00 | +3.2% | +1.1% | -24.0% | |
| Oct 10, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 1,100 | $6.41 | $7,051.00 | +0.7% | -3.9% | -27.1% | |
| Oct 6, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 1,530 | $6.48 | $9,914.40 | +1.0% | -5.4% | -25.7% | |
| Oct 5, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 2,000 | $6.47 | $12,940.00 | +1.3% | -0.8% | -22.7% | |
| Oct 4, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 5,000 | $6.40 | $32,000.00 | +3.4% | -8.1% | -27.9% | |
| Oct 3, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 2,500 | $6.30 | $15,750.00 | +1.7% | -7.8% | -28.2% | |
| Sep 29, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 4,000 | $6.16 | $24,640.00 | +2.4% | -12.9% | -24.0% | |
| Sep 28, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 5,000 | $6.22 | $31,100.00 | +3.0% | -12.9% | -22.4% | |
| Sep 27, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 1,500 | $5.95 | $8,925.00 | +0.9% | -13.3% | -16.8% |